Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
PK of Enmetazobactam + Cefepime in Renal Impairment
NCT03680352Phase 1Completed
- Sponsor
- Allecra Therapeutics
- Start
- Sep 2017
- Primary completion
- Dec 2018
- Modality
- Small Molecules
- Countries
- 2
01
Overview
Phase 1, open-label trial of enmetazobactam in complicated urinary tract infection (cUTI) (5 arms), sponsored by Allecra Therapeutics. Primary endpoints: Maximum Plasma Concentration and Area Under the Concentration-Time Curve from Time 0 to Infinity. Started Sep 2017; status: completed.
02
Drugs
enmetazobactam
03
Conditions
complicated urinary tract infection (cUTI)
Beyond the preview
Go deeper on NCT03680352.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT03680352.